Status:
COMPLETED
Effect of Expanding (Gloving) Barrier Precautions for Reducing Clostridium Difficile Acquisition (and Infection) in VA
Lead Sponsor:
VA Office of Research and Development
Collaborating Sponsors:
University of Wisconsin, Madison
Conditions:
Clostridium Difficile
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Clostridium difficile (C. difficile) is a major pathogen causing serious healthcare-associated diarrheal illness in patients. Prevention of healthcare facility-onset C. difficile infection (CDI) is es...
Detailed Description
Background: Clostridium difficile infection (CDI) has become the most common healthcare-associated infection (HAI) in US hospitals, causing approximately 500,000 infections and 30,000 deaths per year....
Eligibility Criteria
Inclusion
- VA inpatient units meeting the following criteria are eligible to participate in the study:
- Ability to identify one of the following inpatient units as defined by Centers for Disease Control (CDC) National Healthcare Safety Network30 by reviewing prior 12-month patient mix data (at least 80% of patients meet patient type):
- Adult Acute Medical Ward: Hospital area for the evaluation and treatment of patients with medical conditions or disorders.
- Adult Acute Medical/Surgical Ward: Hospital area for the evaluation of patients with medical and/or surgical conditions.
- Adult Acute Surgical Ward: Hospital area for evaluation and treatment of patients who have undergone a surgical procedure.
- Ability to collect and upload data (HAIs, mortality, length of stay, hand hygiene and barrier precaution compliance; glove use and glove plus gown use for contact precautions) required for analysis.
- Local R\&D Committee approval.
- Letter of support from the Hospital Director or Chief of Staff.
- Ability to enroll one unit to intervention and one unit to control.
- To participate in interviews or focus groups, the individual must be:
- 18 years of age or older
- A patient admitted to the participating unit OR a healthcare worker who has regular work duties on the participating unit.
Exclusion
- Intensive care units
- Long term care units
Key Trial Info
Start Date :
March 29 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2024
Estimated Enrollment :
780 Patients enrolled
Trial Details
Trial ID
NCT04036058
Start Date
March 29 2022
End Date
September 30 2024
Last Update
July 11 2025
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington DC VA Medical Center, Washington, DC
Washington D.C., District of Columbia, United States, 20422-0001
2
Edward Hines Jr. VA Hospital, Hines, IL
Hines, Illinois, United States, 60141-3030
3
James J. Peters VA Medical Center, Bronx, NY
The Bronx, New York, United States, 10468-3904
4
VA Portland Health Care System, Portland, OR
Portland, Oregon, United States, 97207-2964